[Diabetes mellitus, inflammation and coronary atherosclerosis: current and future perspectives] (Q54004598)

23 May 2018

review article

1 reference

title

[Diabetes mellitus, inflammation and coronary atherosclerosis: current and future perspectives] (English)

1 reference

23 May 2018

0 references

1 reference

Sánchez-Recalde A

1

1 reference

23 May 2018

Carlos Kaski J

series ordinal

2

1 reference

23 May 2018

publication date

1 June 2001

1 reference

23 May 2018

Revista Española de Cardiología

published in

1 reference

23 May 2018

volume

54

1 reference

23 May 2018

issue

6

1 reference

23 May 2018

page(s)

751-763

1 reference

23 May 2018

Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Diabetes and cardiovascular risk factors: the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Diabetes and cardiovascular disease. The Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Emerging concepts in the management of acute myocardial infarction in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin: evidence for a complex interaction in a multicenter trial. EPILOG Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Inf

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Diabetes and decline in heart disease mortality in US adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

The Effect of Previous Coronary-Artery Bypass Surgery on the Prognosis of Patients with Diabetes Who Have Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Diabetes and outcomes of coronary artery bypass graft surgery in patients with severe left ventricular dysfunction: results from The CABG Patch Trial database. The CABG Patch Trial Investigators and Coordinators

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Hypertriglyceridemia, insulin resistance, and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Coronary artery disease risk predicted by insulin resistance, plasma lipids, and hypertension in people without diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Insulin resistance: syndrome or tendency?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Insulin resistance and lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Insulin resistance and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Fatty acid regulation of very low density lipoprotein production

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Cellular mechanisms of insulin resistance in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Insulin resistance implications for type II diabetes mellitus and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Insulin resistance and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

1 reference

7 January 2021

Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Microvascular function relates to insulin sensitivity and blood pressure in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: a potential factor predisposing to thrombosis and its persistence

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS).

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Insulin and risk of cardiovascular disease: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Insulin as a predictor of coronary heart disease: interaction with apolipoprotein E phenotype. A report from the Multiple Risk Factor Intervention Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Acute-phase proteins and other systemic responses to inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Relation between plasma tumor necrosis factor-alpha and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Is type II diabetes mellitus a disease of the innate immune system?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Assessment and treatment of endothelial dysfunction in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

In Vivo Low Density Lipoprotein Oxidation Relates to Coronary Reactivity in Young Men

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Molecular bases of the acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo : a specific vascular action of insulin.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 1. Pathogenesis of coronary disease: the biologic role of risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Reduced stimulatory activity on prostacyclin production by cultured endothelial cells in serum from aged and diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Circulating endothelin-1 levels increase during euglycemic hyperinsulinemic clamp in lean NIDDM men.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes : 5-year follow-up of the Hoorn Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Atherogenesis: current understanding of the causes of atheroma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Coronary plaque disruption.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Acute coronary thrombosis--the role of plaque disruption and its initiation and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Reactive oxygen species, metalloproteinases, and plaque stability

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Platelet abnormalities in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Thromboxane biosynthesis and platelet function in type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Increased plasminogen activator inhibitor-1 and vasculopathy. A reconcilable paradox

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Potential mechanisms promoting restenosis in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Dealing with in-stent restenosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Insulin signaling in the arterial wall

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Platelets and restenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Lilly Lecture 1993. Glycation and diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Prevention of coronary restenosis : the evolving evidence base for radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Nuclear factor-kappaB is selectively and markedly activated in humans with unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Hyperinsulinemia enhances transcriptional activity of nuclear factor-kappaB induced by angiotensin II, hyperglycemia, and advanced glycosylation end products in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

PPARgamma, the ultimate thrifty gene

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Thiazolidinediones down-regulate plasminogen activator inhibitor type 1 expression in human vascular endothelial cells: A possible role for PPARgamma in endothelial function.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

CLA-1/SR-BI Is Expressed in Atherosclerotic Lesion Macrophages and Regulated by Activators of Peroxisome Proliferator-Activated Receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Differential regulation of macrophage peroxisome proliferator-activated receptor expression by glucose : role of peroxisome proliferator-activated receptors in lipoprotein lipase gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Effects of troglitazone on frequency of coronary vasospastic-induced angina pectoris in patients with diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Troglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with non-insulin dependent diabetes mellitus: a serial intravascular ultrasound study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

The evolving role of statins in the management of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Serum insulin-like growth factor-I level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: beneficial effects of bezafibrate treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Glycoprotein IIb/IIIa receptor blockade improves outcomes in diabetic patients presenting with unstable angina/non-ST-elevation myocardial infarction: results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Antioxidants and atherosclerotic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

Abnormal glucose tolerance, not small vessel diameter, is a determinant of long-term prognosis in patients treated with balloon coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2801%2976390-7

7 January 2021

10.1016/S0300-8932(01)76390-7

Identifiers

DOI

1 reference

23 May 2018

1 reference

23 May 2018